Liquid and Synthetic Biopsies Are Poised to Rewrite Cancer Care

Area of Science:

• Oncology
• Biotechnology
• Molecular Diagnostics

Background:

• Traditional tissue biopsy is invasive and can be challenging for cancer detection and monitoring.
• Liquid biopsy offers a less invasive alternative by analyzing cancer biomarkers in bodily fluids.
• Synthetic biopsy complements liquid biopsy by inducing biomarker production in cancer cells.

Purpose of the Study:

• To explore the current applications and future potential of liquid and synthetic biopsies in oncology.
• To highlight the integration of these biopsy techniques into various aspects of cancer care.
• To discuss their role in screening, early detection, disease progression tracking, therapeutic monitoring, and MRD assessment.

Main Methods:

• Analysis of cancer-related biomarkers, including circulating tumor DNA (ctDNA) and other genetic material, in blood and other body fluids.
• Application of synthetic biopsy techniques to enhance biomarker detection.
• Review of existing and emerging clinical applications of liquid biopsy.

Main Results:

• Liquid biopsy is established for identifying actionable mutations for targeted therapies.
• Ongoing research focuses on expanding liquid biopsy applications beyond mutation detection.
• Integration into screening, early detection, and MRD assessment shows significant promise.

Conclusions:

• Liquid and synthetic biopsies represent a significant advancement in cancer diagnostics and management.
• These innovative approaches are poised to transform multiple stages of cancer care.
• Further research and clinical integration are expected to enhance patient outcomes through improved cancer detection and monitoring.